Status:
COMPLETED
Platelet-activating Factor Acetylhydrolase (Paf-ah) Gene Expression
Lead Sponsor:
University of Utah
Conditions:
Low Birth Weight Infant
Eligibility:
All Genders
Up to 5 years
Brief Summary
This is a prospective observational study to determine whether there is an association between the presence of platelet-activating factor acetylhydrolase (PAF-AH) gene polymorphisms and the developmen...
Detailed Description
Chronic lung disease (CLD) is a frequent and severe complication of premature birth. Between 3,000 and 7,000 infants develop CLD per year in the United States \[6, 7\]. Mortality rates for infants wit...
Eligibility Criteria
Inclusion
- Patients hospitalized in the NICU who:
- weigh ≤ 1500 grams at birth,
- are enrolled at age ≤ 5 days,
- require mechanical ventilation or continuous positive airway pressure (CPAP),
- have parents or guardians that have signed the informed consent document.
Exclusion
- Infants with major congenital anomalies will be excluded.
Key Trial Info
Start Date :
February 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT00747240
Start Date
February 1 2002
End Date
December 1 2014
Last Update
May 12 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84108
2
Primary Children's Medical Center
Salt Lake City, Utah, United States, 84112